|
TTC31 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.57172102794357E-14 |
| Normal-vs-Stage2 |
1.53433999999786E-05 |
| Normal-vs-Stage3 |
1.78200000000572E-06 |
| Normal-vs-Stage4 |
5.402400E-02 |
| Stage1-vs-Stage2 |
2.783600E-01 |
| Stage1-vs-Stage3 |
2.437000E-01 |
| Stage1-vs-Stage4 |
3.877600E-01 |
| Stage2-vs-Stage3 |
9.696000E-01 |
| Stage2-vs-Stage4 |
1.341370E-01 |
| Stage3-vs-Stage4 |
1.647160E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
7.5511999986233E-09 |
| Normal-vs-Asian |
9.141900E-02 |
| Caucasian-vs-AfricanAmerican |
5.185000E-01 |
| Caucasian-vs-Asian |
8.723400E-01 |
| AfricanAmerican-vs-Asian |
9.495600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62447832963153E-12 |
| Normal-vs-Female |
2.55889753830729E-11 |
| Male-vs-Female |
6.818400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.260399999925E-07 |
| Normal-vs-Extreme_Weight |
1.73310255036085E-11 |
| Normal-vs-Obese |
3.48050477327888E-11 |
| Normal-vs-Extreme_Obese |
2.607600E-02 |
| Normal_Weight-vs-Extreme_Weight |
4.943400E-01 |
| Normal_Weight-vs-Obese |
6.965900E-02 |
| Normal_Weight-vs-Extreme_Obese |
8.765800E-01 |
| Extreme_Weight-vs-Obese |
1.964800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.237800E-01 |
| Obese-vs-Extreme_Obese |
4.194400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.55097999999798E-05 |
| Normal-vs-Age(41-60Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(61-80Yrs) |
1.96465066437668E-12 |
| Normal-vs-Age(81-100Yrs) |
2.135800E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.678200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.629620E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.252410E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.452400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.905770E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.721800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62436730732907E-12 |
| Normal-VS-Type2 PRCC |
1.72459999947527E-07 |
| Normal-VS-KIRP CIMP |
9.103000E-03 |
| Normal-VS-Unclassified PRCC |
8.85980000475683E-08 |
| Type1 PRCC-VS-Type2 PRCC |
2.598900E-04 |
| Type1 PRCC-VS-KIRP CIMP |
1.637840E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
5.296800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
8.271200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
5.980800E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
1.417610E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.19889999728696E-08 |
| Normal-vs-N1 |
1.71233999999298E-05 |
| Normal-vs-N2 |
3.591800E-01 |
| N0-vs-N1 |
2.744000E-01 |
| N0-vs-N2 |
4.115600E-01 |
| N1-vs-N2 |
2.266600E-01 |
|
|
